{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:27:34Z","timestamp":1769149654844,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T00:00:00Z","timestamp":1598054400000},"content-version":"vor","delay-in-days":783,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis Institutes for Biomedical research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1074\/jbc.ra118.002633","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T14:41:32Z","timestamp":1529073692000},"page":"11837-11849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Protein kinase A activation inhibits DUX4 gene expression in myotubes from patients with facioscapulohumeral muscular dystrophy"],"prefix":"10.1016","volume":"293","author":[{"given":"Joseph M.","family":"Cruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Hupper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz S.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Concannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berndt","family":"Oberhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystyna","family":"Patora-Komisarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Ulrike","family":"Trendelenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA118.002633_bib1","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1002\/mus.880181315","article-title":"Facioscapulohumeral muscular dystrophy in the Dutch population","volume":"2","author":"Padberg","year":"1995","journal-title":"Muscle Nerve Suppl"},{"key":"10.1074\/jbc.RA118.002633_bib2","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/brain\/awp236","article-title":"Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population","volume":"132","author":"Norwood","year":"2009","journal-title":"Brain"},{"key":"10.1074\/jbc.RA118.002633_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1399-0004.2009.01158.x","article-title":"Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample","volume":"75","author":"Mostacciuolo","year":"2009","journal-title":"Clin. Genet"},{"key":"10.1074\/jbc.RA118.002633_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0960-8966(01)00201-2","article-title":"Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy","volume":"11","author":"Flanigan","year":"2001","journal-title":"Neuromuscul. Disord"},{"key":"10.1074\/jbc.RA118.002633_bib5","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"10.1074\/jbc.RA118.002633_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-203411","article-title":"Beevor's sign in facioscapulohumeral muscular dystrophy","volume":"2014","author":"Sharma","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1074\/jbc.RA118.002633_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-32-4-640","article-title":"Studies in disorders of muscle. II Clinical manifestations and inheritance of facioscapulohumeral dystrophy in a large family","volume":"32","author":"Tyler","year":"1950","journal-title":"Ann. Intern. Med"},{"key":"10.1074\/jbc.RA118.002633_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbadis.2006.05.009","article-title":"Facioscapulohumeral muscular dystrophy","volume":"1772","author":"van der Maarel","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA118.002633_bib9","first-page":"CD003278","article-title":"Scapular fixation in muscular dystrophy","author":"Mummery","year":"2003","journal-title":"Cochrane Database Syst. Rev"},{"key":"10.1074\/jbc.RA118.002633_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12893-017-0276-0","article-title":"Surgical correction of hyperlordosis in facioscapulohumeral muscular dystrophy: A case report","volume":"17","author":"Tan","year":"2017","journal-title":"BMC Surg"},{"key":"10.1074\/jbc.RA118.002633_bib11","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","article-title":"FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit","volume":"2","author":"van Deutekom","year":"1993","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.002633_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ng0992-26","article-title":"Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy","volume":"2","author":"Wijmenga","year":"1992","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.RA118.002633_bib13","doi-asserted-by":"crossref","first-page":"e115278","DOI":"10.1371\/journal.pone.0115278","article-title":"DNA methylation analysis of the macrosatellite repeat associated with FSHD muscular dystrophy at single nucleotide level","volume":"9","author":"Huichalaf","year":"2014","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA118.002633_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1868-7083-6-23","article-title":"Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing","volume":"6","author":"Jones","year":"2014","journal-title":"Clin. Epigenetics"},{"key":"10.1074\/jbc.RA118.002633_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ng1262","article-title":"Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy","volume":"35","author":"van Overveld","year":"2003","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.RA118.002633_bib16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cell.2012.03.035","article-title":"A long ncRNA links copy number variation to a polycomb\/trithorax epigenetic switch in FSHD muscular dystrophy","volume":"149","author":"Cabianca","year":"2012","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.002633_bib17","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1128\/MCB.00149-14","article-title":"Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene","volume":"34","author":"Himeda","year":"2014","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.RA118.002633_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2044-5040-4-12","article-title":"Facioscapulohumeral dystrophy: the path to consensus on pathophysiology","volume":"4","author":"Tawil","year":"2014","journal-title":"Skelet. Muscle"},{"key":"10.1074\/jbc.RA118.002633_bib19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.chembiol.2016.05.016","article-title":"Evidence-based and quantitative prioritization of tool compounds in phenotypic drug discovery","volume":"23","author":"Wang","year":"2016","journal-title":"Cell Chem. Biol"},{"key":"10.1074\/jbc.RA118.002633_bib20","unstructured":"Liu, S., Ginzberg, M. B., Patel, N., Hild, M., Leung, B., Chen, Y.-C., Li, Z., Chang, N., Diena, S., Wang, Y., Trimble, W., Wasserman, L., Jenkins, J., Kirschner, M. W., and Kafri, R., (2017)"},{"key":"10.1074\/jbc.RA118.002633_bib21","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1093\/hmg\/ddt314","article-title":"Wnt\/\u03b2-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells","volume":"22","author":"Block","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.002633_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","article-title":"DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy","volume":"22","author":"Geng","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1074\/jbc.RA118.002633_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cellsig.2017.09.015","article-title":"New kids on the block: the Popeye domain containing (POPDC) protein family acting as a novel class of cAMP effector proteins in striated muscle","volume":"40","author":"Brand","year":"2017","journal-title":"Cell. Signal"},{"key":"10.1074\/jbc.RA118.002633_bib24","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.2174\/1381612811319260005","article-title":"Rational approaches towards lead optimization of kinase inhibitors: the issue of specificity","volume":"19","author":"Badrinarayan","year":"2013","journal-title":"Curr. Pharm. Des"},{"key":"10.1074\/jbc.RA118.002633_bib25","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1074\/jbc.275.18.13812","article-title":"Activated 3\u2032,5\u2032-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line","volume":"275","author":"Cox","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.002633_bib26","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.002633_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nmd.2007.04.002","article-title":"The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein","volume":"17","author":"Kowaljow","year":"2007","journal-title":"Neuromuscul. Disord"},{"key":"10.1074\/jbc.RA118.002633_bib28","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/hmg\/ddp180","article-title":"RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy","volume":"18","author":"Snider","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA118.002633_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JND-150077","article-title":"Immunohistochemical characterization of facioscapulohumeral muscular dystrophy muscle biopsies","volume":"2","author":"Statland","year":"2015","journal-title":"J. Neuromuscul. Dis"},{"key":"10.1074\/jbc.RA118.002633_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/jmg.33.5.366","article-title":"Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy","volume":"33","author":"Tupler","year":"1996","journal-title":"J. Med. Genet"},{"key":"10.1074\/jbc.RA118.002633_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13395-017-0134-x","article-title":"BET bromodomain inhibitors and agonists of the \u03b2-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells","volume":"7","author":"Campbell","year":"2017","journal-title":"Skelet. Muscle"},{"key":"10.1074\/jbc.RA118.002633_bib32","doi-asserted-by":"crossref","first-page":"re4","DOI":"10.1126\/scisignal.122re4","article-title":"Pharmacological PKA inhibition: all may not be what it seems","volume":"1","author":"Murray","year":"2008","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.RA118.002633_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pharmthera.2004.06.003","article-title":"Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation","volume":"103","author":"Hata","year":"2004","journal-title":"Pharmacol. Ther"},{"key":"10.1074\/jbc.RA118.002633_bib34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/mus.10092","article-title":"Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor","volume":"25","author":"Hinkle","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1074\/jbc.RA118.002633_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1042\/bj2610965","article-title":"The action of the \u03b2-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscles","volume":"261","author":"Maltin","year":"1989","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.RA118.002633_bib36","doi-asserted-by":"crossref","first-page":"23042","DOI":"10.1038\/srep23042","article-title":"Using AAV vectors expressing the \u03b22-adrenoceptor or associated G\u03b1 proteins to modulate skeletal muscle mass and muscle fibre size","volume":"6","author":"Hagg","year":"2016","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA118.002633_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2007.09.009","article-title":"The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle","volume":"6","author":"Clarke","year":"2007","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.RA118.002633_bib38","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.002633_bib39","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1055\/s-0031-1285867","article-title":"Skeletal muscle differentiation: role of dehydroepiandrosterone sulfate","volume":"43","author":"Ceci","year":"2011","journal-title":"Horm. Metab. Res"},{"key":"10.1074\/jbc.RA118.002633_bib40","first-page":"E176","article-title":"Clenbuterol mimics effects of innervation on myogenic regulatory factor expression","volume":"265","author":"Maltin","year":"1993","journal-title":"Am. J. Physiol"},{"key":"10.1074\/jbc.RA118.002633_bib41","doi-asserted-by":"crossref","first-page":"712","DOI":"10.18632\/aging.100926","article-title":"A robust neuromuscular system protects rat and human skeletal muscle from sarcopenia","volume":"8","author":"Pann\u00e9rec","year":"2016","journal-title":"Aging"},{"key":"10.1074\/jbc.RA118.002633_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2010.09.004","article-title":"Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases","volume":"143","author":"Moresi","year":"2010","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.002633_bib43","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/01.WNL.0000134660.30793.1F","article-title":"Strength training and albuterol in facioscapulohumeral muscular dystrophy","volume":"63","author":"van der Kooi","year":"2004","journal-title":"Neurology"},{"key":"10.1074\/jbc.RA118.002633_bib44","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.57.8.1434","article-title":"Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy","volume":"57","author":"Kissel","year":"2001","journal-title":"Neurology"},{"key":"10.1074\/jbc.RA118.002633_bib45","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.apmr.2008.12.027","article-title":"Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial","volume":"90","author":"Payan","year":"2009","journal-title":"Arch. Phys. Med. Rehabil"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820317774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820317774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA118.002633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:37:53Z","timestamp":1641271073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820317774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":45,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0021925820317774"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra118.002633","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein kinase A activation inhibits DUX4 gene expression in myotubes from patients with facioscapulohumeral muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA118.002633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Cruz et al.","name":"copyright","label":"Copyright"}]}}